University of Vienna, W?hringer Stra?e 42, 1090 Vienna, Austria Current anticancer drug development aims at finding new therapies with increased clinical efficacy and tolerability by improved targeting of the specificities of malignant tumours. Promising compounds have been identified in various classes of metal complexes which are now in different stages of preclinical or clinical development.
展开▼
